This study investigated the relationship between fibrinogen-to-albumin ratio (FAR) and glucose metabolic state in patients with coronary heart disease (CHD). A total of 52,062 patients were enrolled in this study. Patients were classified according to FAR tertiles (T1: FAR < 0.0073; T2: 0.0073 ≤ FAR ≤ 0.0886; T3: FAR ≥ 0.0887). Patients were also classified into the normal glucose regulation (NGR) and elevated blood glucose (EBG) groups. The relationship between FAR and EBG was analyzed using logistic regression, and the association was evaluated according to sex and age. Among the participants, 32,471 (62.4%) had EBG, which was positively associated with FAR (odds ratio [OR], 1.19; 95% confidence interval [CI] 1.15-1.23). The OR of the FAR for EBG in males was higher than that in females (1.25; 95% CI 1.18-1.33 vs 1.15; 95% CI 1.10-1.20). Moreover, the OR of FAR for EBG was greater in patients aged 60 or younger (OR: 1.25; 95% CI 1.18-1.33) than in the elderly patients (over 60 years of age) (OR: 1.15; 95% CI 1.10-1.20). The results indicated a significant relationship between FAR and EBG and this association was higher in males and middle-aged patients.
LeeYTHFangJSchiebL, et al. Prevalence and trends of coronary heart disease in the United States, 2011 to 2018. JAMA Cardiol. 2022;7:459-462.
2.
LiuYLiZWangX, et al.Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris: a population-based retrospective cohort study. Acupuncture and Herbal Med. 2022;2:109-117.
3.
LyngeTHSvaneJPedersen-BjergaardU, et al.Sudden cardiac death among persons with diabetes aged 1-49 years: a 10-year nationwide study of 14 294 deaths in Denmark. Eur Heart J. 2020;41:2699-2706.
4.
CaiXZhangYLiM, et al.Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. Br Med J. 2020;370:m2297.
5.
RohmTVMeierDTOlefskyJM, et al.Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31-55.
6.
LiXWeberNCCohnDM, et al.Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J Clin Med. 2021;10:2419.
7.
HameedIMasoodiSRMirSA, et al.Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6:598.
8.
YuanTYangTChenH, et al.New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247-260.
9.
YuXRuanMWangY, et al.Site-specific albumin-selective ligation to human serum albumin under physiological conditions. Bioconjugate Chem. 2022;33:2332-2340.
10.
KarabağYÇağdaşMRencuzogullariI, et al.Relationship between C‐reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32:e22457.
11.
BintiNNFerdausiNAnikMEK. Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome. PLoS One. 2022;17:e0271882.
12.
YuanDJiangPZhuP, et al.Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study. Cardiovasc Diabetol. 2021;20:143.
13.
TianXXLuoJYLiuF, et al.Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease. BMC Cardiovasc Disord. 2023;23:181-182.
14.
LiBDengHLeiB, et al.The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis. Front Oncol. 2022;12:985377.
15.
LiLZhuQWangZ, et al.Establishment and validation of a predictive nomogram for gestational diabetes mellitus during early pregnancy term: A retrospective study. Front Endocrinol. 2023;14:1087994.
16.
WangKXuWZhaB, et al.Fibrinogen to albumin ratio as an independent risk factor for type 2 diabetic kidney disease. Diabetes, Metab Syndrome Obes Targets Ther. 2021;4:4557-4567.
17.
KimKSOhARParkJ, et al.Association between Fibrinogen-to-albumin ratio and prognosis in patients admitted to an intensive care unit. J Clin Med. 2023;12:1407.
18.
RuanYYuanCLiuY, et al.High fibrinogen-to-albumin ratio is associated with hemorrhagic transformation in acute ischemic stroke patients. Brain and behavior. 2021;11:e01855.
19.
HuangRDaiQChangL, et al.The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states. Cardiovasc Diabetol. 2022;21:241.
20.
YangZJLiuJGeJP, et al.Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National diabetes and metabolic disorders studyEur Heart J. 2012;33:213-220.
21.
TianHSongGXieH, et al.Prevalence of diabetes and impaired fasting glucose among 769792 rural Chinese adults. Diabetes Res Clin Pract. 2009;84:273-278.
22.
YangTLiuYLiL, et al.Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21:1-12.
23.
American Diabetes Association. Addendum. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl. 1):S15-S33.
24.
YuLLiZYangR, et al.Impaired sensitivity to thyroid hormones is associated with elevated blood glucose in coronary heart disease. Front Endocrinol. 2022;13:895843.
25.
SunFZhaoWShenH, et al.Design of smart aggregates: toward rapid clinical diagnosis of hyperlipidemia in human blood. Adv Mater. 2022;34:e2207671.
26.
ZhouBCarrillo-LarcoRMDanaeiG, et al.Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957-980.
27.
KilmerGHughesEZhangX, et al.Diabetes and prediabetes. Am J Prev Med. 2011;40:159-165.
28.
GoldfineABPhuaEJAbrahamsonMJ. Glycemic management in patients with coronary artery disease and prediabetes or type 2 diabetes mellitus. Circulation. 2014;129:2567-2573.
29.
XuWTianMZhouY. The relationship between insulin resistance, adiponectin and C-reactive protein and vascular endothelial injury in diabetic patients with coronary heart disease. Exp Ther Med. 2018;16:2022.
30.
ShenHWangSZhangC, et al.Association of hyperglycemia ratio and ventricular arrhythmia in critically ill patients admitted to the intensive care unit. BMC Cardiovasc Disord. 2023;23:215.
31.
WangMSuWCaoN, et al.Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22:63.
32.
ZhangCShenHCLiangWR, et al.Relationship between stress hyperglycemia ratio and allcause mortality in critically ill patients: Results from the MIMIC-IV database. Front Endocrinol. 2023;14:1111026.
33.
SiaCHChanMHHZhengH, et al.Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients. Cardiovasc Diabetol. 2021;20:211-214.
34.
GuoWZhuJLiuW. Stress hyperglycemia ratio: an independent predictor for in-hospital major adverse cardiovascular and cerebrovascular events in patients with st-segment elevation myocardial infarction. BMC Cardiovasc Disord. 2023;23:195-212.
35.
UygurBÇelikÖDemirAR, et al.Epicardial adipose tissue volume predicts long term major adverse cardiovascular events in patients with Type 2 diabetes. Turk Kardiyol Dernegi Arsivi. 2021;49.
36.
DuanZLuoCFuB, et al.Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome. BMC Cardiovasc Disord. 2021;21:588.
37.
ErdoğanGArslanUYenercağM, et al.Relationship between the fibrinogen-to-albumin ratio and SYNTAX score in patients with non-st-elevation myocardial infarction. Rev Invest Clin. 2021;73:182-189.
38.
LiMTangCLuoE, et al.Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-ST elevation acute coronary syndrome. BioMed Res Int. 2020;2020.
39.
ZhangDPMaoXFWuTT, et al.The fibrinogen-to-albumin ratio is associated with outcomes in patients with coronary artery disease who underwent percutaneous coronary intervention. Clin Appl Thromb Hemost. 2020;26:1076029620933008.
40.
ParkSNamKKimTK. Association between preoperative fibrinogen-to-albumin ratio and all-cause mortality after off-pump coronary artery bypass grafting: a retrospective observational study. Anesth Analg. 2022;134:1021-1027.
41.
WangPYuanDZhangC, et al.High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21:46.
42.
TanHBZhaoQChenL. Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2. Int Immunopharm. 2022;107:108680.
43.
AngLThaniKBIlapakurtiM, et al.Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. J Am Coll Cardiol. 2013;61:23-34.
44.
DeveciBGaziE. Relation between globulin, fibrinogen, and albumin with the presence and severity of coronary artery disease. Angiology. 2021;72:174-180.
45.
BarazzoniRZanettiMDavanzoG, et al.Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J Clin Endocrinol Metab. 2000;85:3121.
46.
MikhailidisDPGanotakisES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7:125-137.
47.
HuFLouYShiJ, et al.Baseline serum albumin and its dynamic change is associated with type 2 diabetes risk: a large cohort study in China. Diabetes/metabolism research and reviews. 2020;36:e3296.
48.
JiménezJJIribarrenJLBrouardM, et al.Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg. 2011;6:1-10.
49.
MaiWLiaoY. Targeting IL-1β in the Treatment of Atherosclerosis. Front Immunol. 2020;11:589654.
50.
CiarambinoTCrispinoPLetoG, et al.Influence of gender in diabetes mellitus and its complication. Int J Mol Sci. 2022;23:8850.
FuselierTMota de SaPMQadirMMF, et al.Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes. Cell reports. Medicine. 2022;3:100598.
53.
KanBHouJLeslieWD, et al.Associations of estrogen therapy and non-estrogen anti-resorptive therapy with diabetes mellitus risk: A classical and Bayesian meta-analysis. Bone. 2023;171:116738.
54.
TianoJPMauvais-JarvisF. Importance of oestrogen receptors to preserve functional β-cell mass in diabetes. Nat Rev Endocrinol. 2012;8:342-351.
55.
ParkMHKimDHLeeEK, et al. Age-related inflammation and insulin resistance: a review of their intricate interdependency. Arch Pharm Res. 2014;37:1507-1514.
56.
Gayoso-DizPOtero-GonzalezARodriguez-AlvarezMX, et al.Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res Clin Pract. 2011;94:146-155.
57.
SpinettiGMutoliMGrecoS, et al.Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems. Cardiovasc Diabetol. 2023;22:122.
58.
BhaumikDScottGKSchokrpurS, et al.MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging. 2009;1:402.
59.
MensàEGiulianiAMatacchioneG, et al.Circulating miR-146a in healthy aging and type 2 diabetes: age-and gender-specific trajectories. Mech Ageing Dev. 2019;180:1-10.
60.
LiZChengJHuangL, et al.Aging diagnostic probe for research on aging and evaluation of anti-aging drug efficacy. Anal Chem. 2021;93:13800.
61.
SongSHHardistyCA. Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk. Expet Rev Cardiovasc Ther. 2008;6:315-322.
62.
NanayakkaraNCurtisAJHeritierS, et al.Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64:275-287.
63.
TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247-2256.
64.
NanayakkaraNPeaseAJRanasinhaS, et al.Younger people with Type 2 diabetes have poorer self‐care practices compared with older people: results from the Australian National Diabetes Audit. Diabet Med. 2018;35:1087.
65.
ChanJCNLauESHLukAOY, et al.Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med. 2014;127:616-624.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
